EXHIBIT 5 VOTING AGREEMENT VOTING AGREEMENT (this "Agreement"), dated as of November 10, 1996, among BERGEN BRUNSWIG CORPORATION, a New Jersey corporation ("Bergen"), and FROST-NEVADA, LIMITED PARTNERSHIP, a Nevada limited partnership, and DR. PHILLIP...Voting Agreement • November 21st, 1996 • Frost Phillip Md Et Al • Pharmaceutical preparations • New York
AGREEMENT The undersigned hereby agree that this Amendment No. 3 to Schedule 13D filed by us with respect to the Common Stock, no par value, of North American Vaccine, Inc. is filed on behalf of each of us.Agreement • December 17th, 1999 • Frost Phillip Md Et Al • Biological products, (no disgnostic substances)
The undersigned hereby agree that this Amendment No. 3 to Schedule 13D filed by us with respect to the Common Stock, no par value, of North American Vaccine, Inc. is filed on behalf of each of us.
EXHIBIT 6 [FORM OF]Stock Option Agreement • November 25th, 1998 • Frost Phillip Md Et Al • Biological products, (no disgnostic substances) • Quebec
EXHIBIT 2.1Nonqualified Stock Option Agreement • April 6th, 2001 • Frost Phillip Md Et Al • Services-educational services
EXHIBIT 5 SECOND AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP OF FROST-NEVADA LIMITED PARTNERSHIPFrost Phillip Md Et Al • December 17th, 1996 • Blank checks
EXHIBIT 1 The undersigned hereby agree that this Amendment to the Schedule 13D filed by us with respect to the Common Stock of Zanart Entertainment Incorporated is filed on behalf of each of us. /S/ PHILLIP FROST, M.D....Frost Phillip Md Et Al • October 3rd, 1996 • Commercial printing
The undersigned hereby agree that this Amendment to the Schedule 13D filed by us with respect to the Common Stock of Zanart Entertainment Incorporated is filed on behalf of each of us.
THIRD AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP OF FROST-NEVADA LIMITED PARTNERSHIPFrost Phillip Md Et Al • February 2nd, 2000 • Pharmaceutical preparations
NORTH AMERICAN VACCINE, INC. 4.5% CONVERTIBLE SECURED NOTE DUE 2003 No. 2 U.S.$4,250,000Frost Phillip Md Et Al • November 25th, 1998 • Biological products, (no disgnostic substances)
EXHIBIT 5Stock Option Agreement • October 26th, 2000 • Frost Phillip Md Et Al • Services-home health care services • Florida
EXHIBIT 5 THIRD AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP OF FROST- NEVADA LIMITED PARTNERSHIPFrost Phillip Md Et Al • September 18th, 1998 • Services-home health care services
EXHIBIT 8 NORTH AMERICAN VACCINE, INC. SUBSCRIPTION AGREEMENT, made as of this ___ day of _____, 1998 between North American Vaccine, Inc., a corporation organized under the laws of Canada (the "Company"), and the undersigned (the "Subscriber")....Subscription Agreement • November 25th, 1998 • Frost Phillip Md Et Al • Biological products, (no disgnostic substances) • New York
EXHIBIT 4 ===================================================================== =========== AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 21st, 1996 • Frost Phillip Md Et Al • Pharmaceutical preparations • New York
EXHIBIT 6Stock Option Agreement • September 18th, 1998 • Frost Phillip Md Et Al • Services-home health care services • Florida
STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • April 6th, 2018 • Frost Phillip Md Et Al • Services-advertising • Delaware
This STOCKHOLDERS’ AGREEMENT (this “Agreement”), is made and entered into as of March 26, 2018, but shall become effective as of the Spin-Off Date, by and among the Persons listed on Schedule I attached hereto (collectively, the “Stockholders”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 18th, 2016 • Frost Phillip Md Et Al • Services-advertising • Florida
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 9th of May 2016, by and between Barry Honig (the “Seller”) and those persons or entities whose names appear on the signature pages hereto as Purchaser (the “Purchaser”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 20th, 2018 • Frost Phillip Md Et Al • Pharmaceutical preparations • Florida
This Stock Purchase Agreement is dated as of November 8, 2018 (this “Agreement”), between OPKO Health, Inc., a Delaware corporation (the “Company”), and (the “Purchaser”).
CREDIT AGREEMENTCredit Agreement • August 22nd, 2008 • Frost Phillip Md Et Al • Pharmaceutical preparations • Florida
THIS CREDIT AGREEMENT (this “Agreement”), dated as of March 25, 2008 (the “Initial Closing Date”), is entered into by and among Modigene Inc., a Nevada corporation (“Borrower” or the “Company”), and The Frost Group, LLC, a Florida limited liability company (the “Frost Group”).
ContractSecurities Purchase Agreement • May 17th, 2016 • Frost Phillip Md Et Al • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
SECURITIES PURCHASE AGREEMENT (this "Agreement") dated as of May 10, 2016, among the Sellers set forth on Schedule I (each a "Seller" and collectively, the "Sellers"), Frost Gamma Investments Trust, a trust organized under the laws of the State of Florida (the "Purchaser") and Andrew Brooks, M.D., in his capacity as the Representative hereunder.
NOTE AND SECURITY AGREEMENTNote and Security Agreement • August 22nd, 2008 • Frost Phillip Md Et Al • Pharmaceutical preparations • Florida
FOR VALUE RECEIVED, Modigene Inc., a Nevada corporation with offices at 3 Sapir Street, Weizmann Science Park, Nes-Ziona, Israel 74140 ("Borrower"), pursuant to this secured note (this "Note"), hereby promises to pay to The Frost Group, LLC, a Florida limited liability company ("Lender"), at such place as Lender may designate from time to time in writing, in lawful money of the United States of America, the principal amount of $10,000,000, or such lesser amount as shall equal the outstanding principal balance of the loan (the "Loan") made to Borrower by Lender pursuant to the Credit Agreement, dated as of March 25, 2008, by and among Borrower and Lender (the "Credit Agreement"), and to pay all other amounts due with respect to the Loan on the dates and in the amounts set forth in the Credit Agreement and this Note.
IVAX CORPORATION NONQUALIFIED STOCK OPTION AGREEMENT (EMPLOYEE)Corporation Nonqualified Stock Option Agreement • February 2nd, 2000 • Frost Phillip Md Et Al • Pharmaceutical preparations
JOINT FILING AGREEMENTJoint Filing Agreement • February 3rd, 2023 • Frost Phillip Md Et Al • Real estate agents & managers (for others)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.
AGREEMENT TO FILE JOINT SCHEDULE 13DAgreement • January 11th, 2019 • Frost Phillip Md Et Al • Electromedical & electrotherapeutic apparatus
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby consent to the joint filing on their behalf of a single Schedule 13D and any amendments thereto, with respect to the beneficial ownership by each of the undersigned of shares of the common stock of Non-Invasive Monitoring Systems, Inc., a Florida corporation. The undersigned hereby further agree that this statement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • September 15th, 2023 • Frost Phillip Md Et Al • Games, toys & children's vehicles (no dolls & bicycles)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing, along with all other such undersigned, on behalf of the Reporting Persons (as defined in the joint filing), of a statement on Schedule 13D (including amendments thereto) with respect to Nocopi Technologies, Inc., a Maryland corporation, and that this agreement be included as an Exhibit 1 to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is
ContractSecurities Purchase Agreement • August 22nd, 2008 • Frost Phillip Md Et Al • Pharmaceutical preparations • Florida
SECURITIES PURCHASE AGREEMENT (this "Agreement") dated as of July 30, 2008, among Jonathan Fleisig (the "Seller") and the parties set forth on Schedule I hereto (the "Purchasers").
EXHIBIT 1 The undersigned hereby agree that this Amendment to the Schedule 13D filed by us with respect to the Common Stock of IVAX Corporation is filed on behalf of each of us. /S/ PHILLIP FROST, M.D. -------------------------------------- Date:...Frost Phillip Md Et Al • March 28th, 1997 • Pharmaceutical preparations
The undersigned hereby agree that this Amendment to the Schedule 13D filed by us with respect to the Common Stock of IVAX Corporation is filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • April 6th, 2018 • Frost Phillip Md Et Al • Services-prepackaged software
The undersigned hereby agree that this Statement on Schedule 13D, and any amendments thereto filed by any of us, with respect to the stock of Red Violet, Inc. described in this document, signed by each of the undersigned, shall be filed on behalf of each the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
AGREEMENT TO FILE JOINT SCHEDULE 13DAgreement • December 29th, 2017 • Frost Phillip Md Et Al • Medicinal chemicals & botanical products
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby consent to the joint filing on their behalf of a single Schedule 13D and any amendments thereto, with respect to the beneficial ownership by each of the undersigned of shares of the common stock of ChromaDex Corporation, a Delaware corporation. The undersigned hereby further agree that this statement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • December 6th, 2007 • Frost Phillip Md Et Al • Blank checks
The undersigned hereby agree that this Statement on Schedule 13D, and any amendments thereto filed by any of us, with respect to the stock of Ideation Acquisition Corp. described in this document, signed by each of the undersigned, shall be filed on behalf of each the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Tiger X Medical, Inc. 10900 Wilshire Boulevard, Suite #1500 Los Angeles, CA 90024 Ladies and Gentlemen:Merger Agreement • November 10th, 2016 • Frost Phillip Md Et Al • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned understands that Tiger X Medical, Inc. (the “Company”) has entered into an Agreement and Plan of Merger (the “Merger Agreement”) among the Company, BioCardia, Inc. (“BioCardia”) and Icicle Acquisition Corp., a wholly-owned subsidiary of the Company, and the Company Representative and Parent Representative named therein. Pursuant to the Merger Agreement, and subject to the satisfaction of the conditions set forth therein, Merger Sub will merge with and into BioCardia with BioCardia continuing as the surviving entity and continuing its existence as a wholly-owned subsidiary of the Company (the “Merger”). Upon the consummation of the Merger, the holders of capital stock of BioCardia will receive shares of Company common stock (“Common Stock”) on the terms and conditions of the Merger Agreement. Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Merger Agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • April 19th, 2023 • Frost Phillip Md Et Al • Communications equipment, nec
This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.
EXHIBIT 1 The undersigned hereby agree that this Amendment to the Schedule 13D filed by us with respect to the Common Stock of IVAX Corporation is filed on behalf of each of us. /S/ PHILLIP FROST, M.D. -------------------------------------- Date:...Frost Phillip Md Et Al • November 21st, 1996 • Pharmaceutical preparations
The undersigned hereby agree that this Amendment to the Schedule 13D filed by us with respect to the Common Stock of IVAX Corporation is filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • April 6th, 2018 • Frost Phillip Md Et Al • Services-advertising
The undersigned hereby agree that this Statement on Schedule 13D, and any amendments thereto filed by any of us, with respect to the stock of Cogint, Inc. described in this document, signed by each of the undersigned, shall be filed on behalf of each the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AGREEMENTJoint Filing Agreement • September 8th, 2014 • Frost Phillip Md Et Al • Retail-eating places
The undersigned agree that the statement on Schedule 13G, dated September 8, 2014, with respect to the Common Stock of Vaporin, Inc. is, and any amendments hereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13(d) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • November 10th, 2016 • Frost Phillip Md Et Al • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned hereby agree that this Statement on Amendment No. 4 to Schedule 13D with respect to the Common Stock of BioCardia, Inc. of even date herewith is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
THIRD AMENDED AND RESTATED JOINT FILING AGREEMENTJoint Filing Agreement • April 6th, 2015 • Frost Phillip Md Et Al • Services-advertising
This Third Amended and Restated Joint Filing Agreement, dated April 6, 2015 (the “New Joint Filing Agreement”) replaces the Amended and Restated Joint Filing Agreement filed as Exhibit 99.8 to the Schedule 13D/A filed on February 14, 2014 by Frost Gamma Investments Trust and Dr. Phillip Frost. In this New Joint Filing Agreement, the undersigned hereby agree that this Amendment No. 12 amends and supplements the statement on Schedule 13D filed on December 6, 2007, as amended by Amendment No. 1 to the Schedule 13D filed on October 15, 2008, Amendment No. 2 to the Schedule 13D filed on April 13, 2009, Amendment No. 3 to the Schedule 13D filed on May 1, 2009, Amendment No. 4 to the Schedule 13D filed on July 14, 2009, Amendment No. 5 to the Schedule 13D filed on December 24, 2009, Amendment No. 6 to the Schedule 13D filed on November 22, 2011, Amendment No. 7 to the Schedule 13D filed on July 20, 2012, Amendment No. 8 to the Schedule 13D filed on August 23, 2012, Amendment No. 9 to the Sche
